• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Gen Intern Med . Severity Scores in COVID-19 Pneumonia: a Multicenter, Retrospective, Cohort Study

tetano

Editor, Senior Moderator
J Gen Intern Med


. 2021 Feb 11.
doi: 10.1007/s11606-021-06626-7. Online ahead of print.
Severity Scores in COVID-19 Pneumonia: a Multicenter, Retrospective, Cohort Study


Arturo Artero[SUP] 1 [/SUP], Manuel Madrazo[SUP] 2 [/SUP], Mar Fern?ndez-Garc?s[SUP] 3 [/SUP], Antonio Mui?o Miguez[SUP] 4 [/SUP], Andr?s Gonz?lez Garc?a[SUP] 5 [/SUP], Anxela Crestelo Vieitez[SUP] 6 [/SUP], Elena Garc?a Guijarro[SUP] 7 [/SUP], Eva Mar?a Fonseca Aizpuru[SUP] 8 [/SUP], Miriam Garc?a G?mez[SUP] 9 [/SUP], Mar?a Areses Manrique[SUP] 10 [/SUP], Carmen Martinez Cilleros[SUP] 11 [/SUP], Mar?a Del Pilar Fidalgo Moreno[SUP] 12 [/SUP], Jos? Loureiro Amigo[SUP] 13 [/SUP], Ricardo Gil S?nchez[SUP] 14 [/SUP], Elisa Rabad?n Pejenaute[SUP] 15 [/SUP], Lucy Abella V?zquez[SUP] 16 [/SUP], Ruth Ca?izares Navarro[SUP] 17 [/SUP], Marta Nataya Sol?s Marqu?nez[SUP] 18 [/SUP], Francisco Javier Carrasco S?nchez[SUP] 19 [/SUP], Julio Gonz?lez Moraleja[SUP] 20 [/SUP], Lorena Montero Rivas[SUP] 21 [/SUP], Joaqu?n Escobar Sevilla[SUP] 22 [/SUP], Mar?a Dolores Mart?n Escalante[SUP] 23 [/SUP], Ricardo G?mez-Huelgas[SUP] 24 [/SUP], Jos? Manuel Ramos-Rinc?n[SUP] 25 [/SUP], SEMI-COVID-19 Network



Affiliations

Abstract

Background: Identification of patients on admission to hospital with coronavirus infectious disease 2019 (COVID-19) pneumonia who can develop poor outcomes has not yet been comprehensively assessed.
Objective: To compare severity scores used for community-acquired pneumonia to identify high-risk patients with COVID-19 pneumonia.
Design: PSI, CURB-65, qSOFA, and MuLBSTA, a new score for viral pneumonia, were calculated on admission to hospital to identify high-risk patients for in-hospital mortality, admission to an intensive care unit (ICU), or use of mechanical ventilation. Area under receiver operating characteristics curve (AUROC), sensitivity, and specificity for each score were determined and AUROC was compared among them.
Participants: Patients with COVID-19 pneumonia included in the SEMI-COVID-19 Network.
Key results: We examined 10,238 patients with COVID-19. Mean age of patients was 66.6 years and 57.9% were males. The most common comorbidities were as follows: hypertension (49.2%), diabetes (18.8%), and chronic obstructive pulmonary disease (12.8%). Acute respiratory distress syndrome (34.7%) and acute kidney injury (13.9%) were the most common complications. In-hospital mortality was 20.9%. PSI and CURB-65 showed the highest AUROC (0.835 and 0.825, respectively). qSOFA and MuLBSTA had a lower AUROC (0.728 and 0.715, respectively). qSOFA was the most specific score (specificity 95.7%) albeit its sensitivity was only 26.2%. PSI had the highest sensitivity (84.1%) and a specificity of 72.2%.
Conclusions: PSI and CURB-65, specific severity scores for pneumonia, were better than qSOFA and MuLBSTA at predicting mortality in patients with COVID-19 pneumonia. Additionally, qSOFA, the simplest score to perform, was the most specific albeit the least sensitive.

Keywords: COVID-19; CURB-65; PSI; community-acquired pneumonia; qSOFA.
 
Back
Top Bottom